2000至2020年国家中毒数据系统报告的儿童β肾上腺素能受体拮抗剂摄入特征分析
该研究为回顾性分析,纳入2000年1月至2020年2月美国国家中毒数据系统(NPDS)中年龄<20岁、报告单种β肾上腺素能受体拮抗剂(BAA)摄入并就诊于医疗机构且咨询中毒控制中心的患者。共识别35436例报告暴露,其中29155例(82.3%)<6岁,29089例(99.8%)为意外摄入;<6岁仅25例(<0.1%)出现严重效应。全部病例中低血压1460例(4.1%)、心动过缓1403例(4.0%)、低血糖119例(0.3%);仅4例死亡,均为>10岁故意摄入并在院前发生心脏骤停。无/轻微效应患者中2316例(8.8%)入住重症监护室。作者认为,尽管严重中毒需积极治疗,但无/轻微效应者入住ICU比例较高,提示存在降低资源利用的机会。
要点
- 共35436例报告暴露,<6岁29155例(82.3%),其中意外摄入29089例(99.8%)。
- <6岁患者中仅25例(<0.1%)出现严重效应;全部病例中低血压4.1%、心动过缓4.0%、低血糖0.3%。
- 仅4例死亡,均为>10岁故意摄入且院前发生心脏骤停;无意外摄入死亡。
- 无/轻微效应患者中2316例(8.8%)入住重症监护室,作者提示可减少资源利用。
适用人群与场景
- 美国年龄<20岁、报告单种β肾上腺素能受体拮抗剂摄入、就诊于医疗机构并咨询中毒控制中心的患者。
- 数据来源为国家中毒数据系统(NPDS),时间为2000年1月至2020年2月。
诊断标准与关键阈值
- 医学结局采用NPDS量表评估:无效应、轻微效应、中等效应、严重效应、死亡。
红旗征与不能漏的情况
- 低血压1460例(4.1%)和心动过缓1403例(4.0%)为常见严重表现。
- 低血糖119例(0.3%)。
- 4例死亡均为>10岁故意摄入并在院前发生心脏骤停。
研究设计与关键结果
- 研究类型为回顾性分析,数据来自美国国家中毒数据系统(NPDS),共纳入35436例报告暴露。
- 29155例(82.3%)<6岁,其中29089例(99.8%)为意外摄入。
- <6岁患者中25例(<0.1%)出现严重效应。
- 全部病例中低血压1460例(4.1%)、心动过缓1403例(4.0%)、低血糖119例(0.3%)。
- 无/轻微效应患者中2316例(8.8%)入住重症监护室。
- 仅4例死亡,均为>10岁故意摄入并在院前发生心脏骤停。
证据类型、等级与局限
- 证据类型:回顾性分析,数据来自国家中毒数据系统(NPDS)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管严重中毒患者需要积极治疗,但无/轻微效应患者中8.8%入住重症监护室,提示存在减少资源利用的机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: When ingested by children, small quantities of beta-adrenergic antagonists (BAA) are described as dangerous and even potentially lethal ("one pill can kill"). We characterize demographics, clinical characteristics, and the rate of serious outcomes among pediatric patients with reported BAA ingestions.
METHODS: This study was a retrospective review of U.S. patients <20 years old with reported single-agent BAA ingestions presenting to a health care facility between January 2000 and February 2020 for whom a poison control center was consulted. Data were abstracted from the National Poison Data System (NPDS). Medical outcomes were assessed by the NPDS scale of no effect, minor effect, moderate effect, major effect, and death. All relevant NPDS fatality narratives were reviewed.
RESULTS: A total of 35,436 reported exposures were identified. A total of 29,155 (82.3%) were <6 years old, of which 29,089 (99.8%) were unintentional. Twenty-five patients (<0.1%) <6 years old had major effects. A total of 2316 (8.8%) of patients with no/mild effects were admitted to a critical care unit. Of all cases, 1460 (4.1%) had hypotension and 1403 (4.0%) had bradycardia. One hundred nineteen (0.3%) developed hypoglycemia. The only four fatalities resulted from intentional ingestions in patients >10 years old who sustained cardiac arrest in the prehospital setting.
CONCLUSIONS: Reported BAA ingestions in this multiyear national pediatric cohort caused infrequent toxicity, and no fatalities resulted from an unintentional ingestion. The frequency of bradycardia, hypotension, and hypoglycemia were low. While severely poisoned patients require aggressive treatment, 8.8% of patients were admitted to a critical care unit despite having no or mild effects, which suggests an opportunity to reduce resource utilization.
参考来源
- Watson CJ, Monuteaux MC, Burns MM, et al. Characterization of pediatric beta-adrenergic antagonist ingestions reported to the National Poison Data System from 2000 to 2020. Acad Emerg Med. 2023. PMID: 37350748. doi:10.1111/acem.14769
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。